Navigation Links
Antisense gene specific therapy for Ebola virus

Professor Sina Bavari and team from the U.S. Army Medical Research Institute of Infectious Diseases have found that antisense genetic sequence of the Ebola virus could help protection and treatment of humans // from wild strains of Ebola virus. This therapy is very important and still more has to be done as this Ebola virus offers a great threat of bioterrorism. The results of this research work are published in the Journal Public Library of Science Pathogens.

Ebola virus causes Viral Hemorrhagic Syndrome causing a very high increase of virus in blood leading to an ineffective immunological protection by the host against the virus leading necrosis. Morbidity and mortality is very high and varies according to the strain involved and no effective treatment has been found against the virus and interestingly virus has been isolated from the semen of infected person.

Antisense drugs binds to the replication site of the virus and due to the mismatch pairing it does not lead to replication of virus causing the reduction of the virus. A Combination of three Antisense Phosphorodiamidate Morpholino Oligomers (PMOs) was first tested on laboratory mice followed by experiments on guinea pigs and rhesus monkeys and the researchers found that the Antisense PMOs effectively inhibits the growth of the virus and the researchers are planning to further expand their study on antisense PMOs against Ebola virus.


'"/>




Page: 1

Related medicine news :

1. Gene testing kit specific for Doctors
2. Dental appointment fear: is it gender specific?
3. Child specific HIV drugs and laboratory tests should be developed
4. Acupuncture May Help Chemotherapy Side Effects
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. Distraction therapy found very effective in postoperative patients
7. Acupuncture superseeds massage therapy for short term relief of pain
8. Ovarian cancer in relationship with Hormone therapy
9. New therapy better at increasing bone density
10. Gene therapy - Aim to improve blood flow
11. Gene therapy restores sight
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
(Date:10/12/2017)... Texas (PRWEB) , ... October 12, 2017 , ... ... and biologics manufacturer, has expanded its executive staff with the addition of industry ... In this role, Slott will develop the national distribution and sales network, direct ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
Breaking Medicine Technology: